Zfp13 Inhibitors
The chemical class known as Zfp13 Inhibitors comprises a diverse group of compounds that can potentially inhibit the Zfp13 protein through various mechanisms. These inhibitors target different cellular pathways involved in Zfp13 activation and function. GW6471, UVI3003, and CAY10566, as PPAR antagonists, can potentially inhibit Zfp13 by interfering with PPAR-mediated signaling pathways, leading to downstream effects that negatively impact Zfp13 activation.
GSK2334470A, Troglitazone, O-304, AICAR, Rosiglitazone, MK-8722, and Pioglitazone, as AMPK and PPAR agonists, may activate Zfp13 by modulating AMPK and PPAR activity. Activation of these pathways may lead to cellular responses that support Zfp13 activation and contribute to enhanced cellular processes and metabolic functions. Metformin, an AMPK activator, can potentially activate Zfp13 by modulating AMPK activity, contributing to improved cellular processes and overall cellular health.
The diversity in mechanisms displayed by Zfp13 Inhibitors highlights the intricate regulation of Zfp13 and the interconnectedness of cellular pathways influencing its activation. Researchers can employ these inhibitors to unravel the complex regulatory networks associated with Zfp13 and gain insights into potential avenues for modulating Zfp13 function in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 4064 | 278779-30-9 | sc-218577 | 5 mg | $93.00 | 13 | |
GW6471, a selective PPARα antagonist, can potentially inhibit Zfp13 by interfering with PPARα-mediated signaling pathways. This disruption may lead to downstream effects that negatively impact Zfp13 activation and functionality. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $195.00 $1142.00 | 1 | |
GSK2334470A, an AMPK activator, can potentially activate Zfp13 by modulating AMPK activity. Activation of AMPK may lead to cellular responses that support Zfp13 activation and enhance cellular processes associated with Zfp13 function. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $108.00 $200.00 $426.00 | 9 | |
Troglitazone, a PPARγ agonist, can activate Zfp13 by modulating PPARγ activity. Activation of PPARγ may lead to downstream effects that support Zfp13 activation and contribute to enhanced cellular processes and metabolic functions. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin, an AMPK activator, can activate Zfp13 by modulating AMPK activity. Its influence on AMPK may lead to cellular responses that support Zfp13 activation, contributing to enhanced cellular processes and overall cellular health. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR, an AMPK activator, can activate Zfp13 by modulating AMPK activity. By mimicking AMP, AICAR activates AMPK, leading to downstream effects that can support Zfp13 activation and contribute to enhanced cellular function. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Rosiglitazone, a PPARγ agonist, can activate Zfp13 by modulating PPARγ activity. Activation of PPARγ may lead to downstream effects that support Zfp13 activation and contribute to enhanced cellular processes and metabolic functions. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
MK-8722, a liver-specific AMPK activator, can potentially activate Zfp13 by specifically modulating AMPK in the liver. Activation of liver-specific AMPK may lead to cellular responses that support Zfp13 activation and enhance hepatic functions. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Pioglitazone, a PPARγ agonist, can activate Zfp13 by modulating PPARγ activity. Activation of PPARγ may lead to downstream effects that support Zfp13 activation and contribute to enhanced cellular processes and metabolic functions. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A-769662, an AMPK activator, can potentially activate Zfp13 by modulating AMPK activity. Activation of AMPK may lead to cellular responses that support Zfp13 activation and enhance cellular processes associated with Zfp13 function. | ||||||